[May 26, 2016]

Global Idiopathic Pulmonary Fibrosis Pipeline Review, H1 2016 - Analysis, Technologies & Forecasts - Key Vendors: AdAlta, Bioneer Corp, Sanofi - Research and Markets

Research and Markets has announced the addition of the "Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2016" report to their offering.

The report provides comprehensive information on the therapeutics under development for Idiopathic Pulmonary Fibrosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Idiopathic Pulmonary Fibrosis and features dormant and discontinued projects.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Key Topics Covered:

• The report provides a snapshot of the global therapeutic ladscape of Idiopathic Pulmonary Fibrosis
• The report reviews pipeline therapeutics for Idiopathic Pulmonary Fibrosis by companies and universities/research institutes based on information derived from company and industry-specific sources
• The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
• The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
• The report reviews key players involved Idiopathic Pulmonary Fibrosis therapeutics and enlists all their major and minor projects
• The report summarizes all the dormant and discontinued pipeline projects
• The report reviews latest news related to pipeline therapeutics for Idiopathic Pulmonary Fibrosis

• AdAlta Pty Ltd.
• Aeolus Pharmaceuticals, Inc.
• Afferent Pharmaceuticals, Inc.
• Bioneer Corporation
• BiOrion Technologies B.V.
• Bristol-Myers Squibb Company
• Kadmon Corporation, LLC
• Kasiak Research Private Limited
• Kolltan Pharmaceuticals, Inc.
• Pacific Therapeutics Ltd.
• Pharmaxis Limited
• Promedior, Inc.
• ProMetic Life Sciences Inc.
• Pulmatrix, Inc.
• Respira Therapeutics, Inc.
• Ribomic Inc.
• Saje Pharma, LLC
• Sanofi
• Teva Pharmaceutical Industries Ltd.
• Yuhan Corporation

For more information visit http://www.researchandmarkets.com/research/278ptb/idiopathic

View source version on businesswire.com: http://www.businesswire.com/news/home/20160526006497/en/

[ Back To TMCnet.com's Homepage ]